RAAS TRIPLE-A
LIVE

Serial Number

79256903

Owner

ATTOQUANT DIAGNOSTICS GMBH

Attorney

Michael J. Leonard

Filing Date

Dec 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

RAAS TRIPLE-A Trademark

Serial Number: 79256903 • Registration: 5993170

RAAS TRIPLE-A is a trademark filed by ATTOQUANT DIAGNOSTICS GMBH on December 19, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ATTOQUANT DIAGNOSTICS GMBH (4 trademarks)

Campus-Vienna-Biocenter 5
Wien A1030 , AT

Entity Type: 16

Trademark Details

Filing Date

December 19, 2018

Registration Date

February 25, 2020

Published for Opposition

December 10, 2019

Goods & Services

Downloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Medical services, medical care, medical testing in the nature of medical diagnostic testing [ ; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism ]

Chemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system

Medical and scientific research and analysis services in the nature of [ quality measurement and ] analysis for medical practices, [ and software design and development ] concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of [ researching, ] diagnosing, [ preventing, combating, treating, ] and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Diagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Filing History

CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 15, 2026 APRE
TEAS SECTION 71 RECEIVED
Feb 24, 2026 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 25, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 4, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 26, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 25, 2020 FICS
FINAL DISPOSITION PROCESSED
Jun 25, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 25, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 3, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 3, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 3, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 3, 2019 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 17, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 17, 2019 GNFR
FINAL REFUSAL WRITTEN
Sep 17, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2019 CRFA
ASSIGNED TO LIE
Aug 14, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 8, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 22, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 30, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 26, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 25, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 18, 2019 REPR